EVTTX Performance — The E-Valuator Conservative/Moderate (30%-50%) RMS Fund, Service Class Shares
Data updated: 2026-08-25
EVTTX returned +8.42% year to date and +15.23% over one year to Jun 2026. Annualised returns are +10.99% over 3 years and +5.38% over 5 years. Against its Alternative category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $137, against $170 for the category, and to $115 over one year, against $110. Volatility over the past three years was 7.36% a year. In the 12 months to Jun 2026 the fund lost a net $1.2M, and assets reached $34.46M.
EVTTX Growth of $100
What $100 invested in The E-Valuator Conservative/Moderate (30%-50%) RMS Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Alternative category average over the same months.
| Period | EVTTX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $115 | $110 |
| 3 years (Jul 2023 – Jun 2026) | $137 | $170 |
| 5 years (Jul 2021 – Jun 2026) | $130 | $159 |
| Since data start (Apr 2021 – Jun 2026) | $134 | $165 |
EVTTX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +8.42% |
| 1 year | +15.23% |
| 3 years (annualised) | +10.99% |
| 5 years (annualised) | +5.38% |
EVTTX Annual Returns
Calendar-year total returns of The E-Valuator Conservative/Moderate (30%-50%) RMS Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +8.42% |
| 2025 | +13.00% |
| 2024 | +7.24% |
| 2023 | +9.12% |
| 2022 | −11.01% |
| 2021 (Apr–Dec) | +4.74% |
EVTTX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.2% | +1.4% | −3.9% | +5.5% | +2.8% | +0.4% | — | — | — | — | — | — |
| 2025 | +1.7% | +0.1% | −2.0% | +0.6% | +2.9% | +3.0% | +0.7% | +2.1% | +1.7% | +0.9% | +0.4% | +0.2% |
| 2024 | −0.1% | +1.3% | +2.0% | −2.2% | +2.3% | +0.4% | +2.1% | +1.4% | +1.4% | −1.5% | +2.6% | −2.6% |
| 2023 | +3.2% | −1.7% | +1.3% | +0.5% | −1.0% | +2.5% | +1.7% | −1.3% | −2.7% | −1.9% | +4.8% | +3.8% |
| 2022 | −3.1% | −1.0% | +0.1% | −4.2% | 0.0% | −5.0% | +4.1% | −2.0% | −4.9% | +2.8% | +3.4% | −1.3% |
| 2021 | — | — | — | +1.8% | +0.3% | +0.7% | +0.5% | +0.8% | −2.0% | +2.2% | −1.2% | +1.6% |
EVTTX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 7.36%
- 3-year Sharpe ratio: 0.88 (vs 4.5% risk-free rate)
- Best month: +5.45% (Apr 2026)
- Worst month: −3.93% (Mar 2026)
EVTTX Fund Flows
Monthly money in and out of The E-Valuator Conservative/Moderate (30%-50%) RMS Fund, from SEC Form N-PORT.
- 12-month net flow: −$1.2M
- 12-month gross sales (incl. reinvestments): $8.6M
- Sales ÷ redemptions: 0.88×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $396K | $665K | −$269K |
| May 2026 | $102K | $339K | −$237K |
| Apr 2026 | $389K | $586K | −$197K |
| Mar 2026 | $1.1M | $1.9M | −$800K |
| Feb 2026 | $1.2M | $976K | $186K |
| Jan 2026 | $611K | $509K | $101K |
| Dec 2025 | $1.3M | $1.0M | $277K |
| Nov 2025 | $951K | $810K | $141K |
| Oct 2025 | $776K | $638K | $138K |
| Sep 2025 | $440K | $330K | $110K |
| Aug 2025 | $482K | $1.7M | −$1.2M |
| Jul 2025 | $933K | $346K | $587K |
EVTTX Assets Under Management
Net assets of The E-Valuator Conservative/Moderate (30%-50%) RMS Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $34.46M |
| 2026-03-31 | $32.30M |
| 2025-12-31 | $32.97M |
| 2025-09-30 | $32.84M |
| 2025-06-30 | $32.60M |
| 2025-03-31 | $31.24M |
| 2024-12-31 | $30.97M |
| 2024-09-30 | $30.87M |
| 2024-06-30 | $30.26M |
| 2024-03-31 | $29.46M |
| 2023-12-31 | $29.58M |
| 2023-09-30 | $26.79M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.